Richardson Electronics Announces Date of Second Quarter
From GlobeNewswire: Richardson Electronics, Ltd. will release its second quarter financial results for fiscal year 2024 on January 10, 2024,
Category: Earnings
Generation Bio to Present at the 42nd Annual J.P. Morgan
From GlobeNewswire: Generation Bio Co., a biotech company, has announced that its president and CEO, Geoff McDonough, M.D. will present
Myriad Genetics to Present at 42nd Annual J.P. Morgan
From GlobeNewswire: Myriad Genetics will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on January
ResMed to Report Second Quarter Fiscal 2024 Earnings on
From GlobeNewswire: ResMed plans to release financial results for the second quarter of fiscal year 2024 on January 24, 2024,
Morphic to Present at the 42nd Annual J.P. Morgan
From GlobeNewswire: The Chief Executive Officer of Morphic Therapeutic, Dr. Praveen Tipirneni, has returned to full capacity after a medical
Oaktree Specialty Lending Corporation Schedules First
From GlobeNewswire: create short ,engaging summaries of the news. Limit summaries to 50 words or less per paragraph. Ensure clarity
QCR Holdings, Inc. to Report Fourth Quarter and Fiscal Year
From GlobeNewswire: QCR Holdings, Inc. will release its fourth quarter and fiscal year ended December 31, 2023 financial results on
Merit Medical to Present at the J.P. Morgan 42nd Annual
From GlobeNewswire: Merit Medical Systems, Inc. will be represented by Chairman and CEO Fred Lampropoulos at the J.P. Morgan 42nd
BurgerFi to Participate in the 26th Annual ICR Conference
From GlobeNewswire: BurgerFi International will be participating in the 26th Annual ICR Conference on January 9, 2024, hosting a fireside
After-Hours Earnings Report for January 3, 2024 : SLP, RGP
From Nasdaq.: Simulations Plus, Inc. (SLP) is expected to report earnings for the quarter ending November 30, 2023. The consensus
iTeos présentera ses travaux lors de la 42e conférence
From GlobeNewswire: iTeos Therapeutics, Inc. will provide an update on their ongoing work at J.P. Morgan’s 42nd Annual Health Conference
iTeos hält auf der 42. jährlichen Gesundheitskonferenz von
From GlobeNewswire: iTeos Therapeutics, Inc. announced that President and CEO Dr. Michel Detheux will be speaking at the 42nd annual
The First of Long Island Corporation Announces Fourth
From GlobeNewswire: The First of Long Island Corporation (Nasdaq: FLIC) will hold an earnings conference call on January 26, 2024
Near Term Rate Cut Odds Getting Pared Back
From Nasdaq: 1) Markets and Economy: Equities and gold prices are lower, while Treasury yields, oil, and the dollar are
G1 Therapeutics to Participate in the 42nd Annual J.P.
From GlobeNewswire: G1 Therapeutics announced that CEO Jack Bailey will provide a corporate presentation during the 42nd Annual J.P. Morgan
Coherus BioSciences Management to Present at the 42nd
From GlobeNewswire: Coherus BioSciences, Inc. will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024, at
Financial Institutions, Inc. Schedules Fourth Quarter and
From GlobeNewswire: Financial Institutions, Inc. (NASDAQ: FISI) will release results for the fourth quarter and full year ended December 31,
UniFirst Backs FY24 Outlook; Q1 Results Top Estimates
From RTT News: UniFirst Corp. reported first quarter fiscal 2024 financial results, with net income of $42.33 million or $2.26
La-Z-Boy Incorporated to Present at the 2024 ICR
From GlobeNewswire: La-Z-Boy Incorporated will be presenting at the 2024 ICR Conference on January 8, 2024, at 9:30 a.m. Eastern
CRISPR Therapeutics to Present at the 42nd Annual J.P.
From GlobeNewswire: CRISPR Therapeutics will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024, at 2:15
First Watch Restaurant Group, Inc. to Participate in the
From GlobeNewswire: First Watch Restaurant Group, Inc. will participate in two upcoming conferences: the 26th Annual ICR Conference on Jan.
VPG to Present at the 26th Annual Needham Growth Conference
From GlobeNewswire: Vishay Precision Group will be presenting at the Needham Growth Investor Conference on January 18, 2024, at 2:15
Radware Schedules Conference Call for Its Fourth Quarter
From GlobeNewswire: Radware (NASDAQ: RDWR) will announce its Q4 and full year 2023 financial results on February 7, 2024 at
Faron Pharmaceuticals to Present at the 42nd Annual J.P.
From GlobeNewswire: create short ,engaging summaries of the news. Limit summaries to 50 words or less per paragraph. Ensure clarity